Skip to main content

Table 5 Expression changes of microglial effectors in the brain that affect the A1-reactive astrocyte phenotype in PLX5622 treatment of RML-infected mice relative to Untreated RML-infected mice

From: RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection

Gene

80 dpia

100 dpi

~ 127c dpi

FCb

P value

FC

P value

FC

P value

Tnf

−1.05

1.4 × 10− 1

−1.07

1.7 × 10− 2

1.11

3.7 × 10− 1

Il1a

− 1.18

7.0 × 10− 4

− 1.17

3.7 × 10− 3

− 1.17

2.4 × 10− 2

C1qa

− 2.26

6.7 × 10− 2

− 1.76

1.4 × 10− 2

−1.37

3.1 × 10− 1

C1qb

−2.93

4.6 × 10− 3

−2.53

5.5 × 10− 3

− 1.59

8.0 × 10− 2

C1qc

−1.59

5.3 × 10− 1

−1.95

1.3 × 10− 1

−1.86

1.6 × 10− 1

Tgfb1

− 1.50

5.8 × 10− 2

− 1.71

7.0 × 10− 4

−1.39

1.0 × 10− 1

Fgf2

1.09

4.7 × 10− 1

1.37

2.9 × 10− 3

1.13

3.1 × 10− 1

  1. Bolded values denote genes decreased ≥2.0-fold with p values ≤0.05 (5.0 × 10− 2) in infected PX5622-treated mice relative to infected untreated mice
  2. Values in italics are decreased between 1.5-fold and 1.9-fold with p values ≤0.05 (5.0 × 10− 2) in infected PX5622-treated mice relative to infected untreated mice
  3. adpi days post inoculation
  4. bFC fold change
  5. c ~ 127 dpi is the average dpi to clinical endpoint for infected PLX5622-treated mice